(Q34407129)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22954038%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

3 references

29 June 2020

4 July 2020

10 August 2020

Prevention of pneumococcal diseases in the post-seven valent vaccine era: a European perspective (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22954038%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference

2 November 2019

pneumococcal infection

1 reference

29 June 2020

1 reference

4 July 2020

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22954038%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Lorenzo G. Mantovani

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22954038%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

4

Ron Dagan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22954038%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

author name string

Catherine Weil-Olivier

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22954038%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Iris de Schutter

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22954038%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

publication date

7 September 2012

7 references

23 March 2019

20 June 2019

2 November 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22954038%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

29 June 2020

4 July 2020

10 August 2020

BMC Infectious Diseases

7 references

23 March 2019

20 June 2019

2 November 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22954038%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

29 June 2020

4 July 2020

10 August 2020

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22954038%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

page(s)

207

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22954038%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 2.0 Generic

12 February 2020

copyright license

6 references

23 March 2019

20 June 2019

2 November 2019

29 June 2020

4 July 2020

https://scigraph.springernature.com/pub.10.1186/1471-2334-12-207

10 August 2020

0 references

0 references

cites work

13-valent pneumococcal conjugate vaccine (PCV13).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3462147

Divergent mechanisms for passive pneumococcal resistance to β-lactam antibiotics in the presence of Haemophilus influenzae.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3462147

Non-typeable Haemophilus influenzae and Streptococcus pneumoniae as primary causes of acute otitis media in colombian children: a prospective study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3462147

Molecular analysis improves pathogen identification and epidemiologic study of pediatric parapneumonic empyema

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3462147

Continued control of pneumococcal disease in the UK - the impact of vaccination.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3462147

Pneumococcal conjugate vaccine: review of cost-effectiveness studies in Australia, North America and Europe

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3462147

Effects of pneumococcal conjugate vaccine 2 years after its introduction, the Netherlands

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3462147

Dynamic models of pneumococcal carriage and the impact of the Heptavalent Pneumococcal Conjugate Vaccine on invasive pneumococcal disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3462147

Molecular epidemiology of pediatric pneumococcal empyema from 2001 to 2007 in Utah

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3462147

Microbial interactions in the respiratory tract

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3462147

Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3462147

Evolving concepts in biofilm infections

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3462147

Etiology of community-acquired pneumonia in hospitalized children based on WHO clinical guidelines

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3462147

Formation of biofilm by Haemophilus influenzae isolated from pediatric intractable otitis media

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3462147

Biofilms and their role in otorhinolaryngological disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3462147

Empyema: an increasing concern in Canada

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3462147

The impact of indirect (herd) protection on the cost-effectiveness of pneumococcal conjugate vaccine.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3462147

Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3462147

Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3462147

Impact on respiratory tract infections of heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 11 months of age.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3462147

Convincing or confusing? Economic evaluations of childhood pneumococcal conjugate vaccination--a review (2002-2006).

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3462147

Nasopharyngeal colonization: a target for pneumococcal vaccination

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3462147

Brief review of the clinical effectiveness of PREVENAR against otitis media

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3462147

Direct detection of bacterial biofilms on the middle-ear mucosa of children with chronic otitis media

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3462147

Bacterial pneumonia vaccines and childhood pneumonia: are we winning, refining, or redefining?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3462147

Haemophilus influenzae: a significant pathogen in acute otitis media

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3462147

Seven valent pneumococcal conjugate vaccine immunization in two Boston communities: changes in serotypes and antimicrobial susceptibility among Streptococcus pneumoniae isolates

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3462147

Cost-effectiveness analysis of pneumococcal conjugate vaccination in England and Wales.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3462147

Clinical features, aetiology and outcome of empyema in children in the north east of England

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3462147

Modern management of acute otitis media

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3462147

Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3462147

An epidemiological investigation of a sustained high rate of pediatric parapneumonic empyema: risk factors and microbiological associations

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3462147

Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3462147

Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3462147

Epidemiology of invasive pneumococcal infections in children in Finland

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3462147

Proportion of invasive pneumococcal infections in German children preventable by pneumococcal conjugate vaccines.

6 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-207

Changes in pneumococcal serotypes and antibiotypes carried by vaccinated and unvaccinated day-care centre attendees in Portugal, a country with widespread use of the seven-valent pneumococcal conjugate vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-207

Serotypes 1, 7F and 19A became the leading causes of pediatric invasive pneumococcal infections in Portugal after 7 years of heptavalent conjugate vaccine use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-207

Community‐acquired bacteremic pneumococcal pneumonia in children: diagnosis and serotyping by real‐time polymerase chain reaction using blood samples.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-207

The burden of pneumonia in children in the developed world

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-207

Aetiology of community-acquired pneumonia: serological results of a paediatric survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-207

Impact of the seven-valent pneumococcal conjugate vaccination (PCV7) programme on childhood hospital admissions for bacterial pneumonia and empyema in England: national time-trends study, 1997-2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-207

Decline in pneumonia and acute otitis media after the introduction of childhood pneumococcal vaccination in Liguria, Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-207

[Epidemiology and clinical characteristics of childhood parapneumonic empyemas]

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-207

Childhood empyema in North-East Scotland over the past 15 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-207

Potential contribution by nontypable Haemophilus influenzae in protracted and recurrent acute otitis media

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-207

Acute otitis media: bacteriology and bacterial resistance in 205 pediatric patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-207

The burden and outcome of respiratory tract infection in Australian and aboriginal children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-207

Effect of conjugate pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent acute otitis media: a randomised study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-207

Pneumococcal conjugate vaccination in children with recurrent acute otitis media: a therapeutic alternative?

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-207

Trends in acute otitis media-related health care utilization by privately insured young children in the United States, 1997-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-207

A decade-long surveillance of nasopharyngeal colonisation with Streptococcus pneumoniae among children attending day-care centres in south-eastern France: 1999-2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-207

Cost effectiveness of pneumococcal vaccination among Dutch infants: economic analysis of the seven valent pneumococcal conjugated vaccine and forecast for the 10 valent and 13 valent vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-207

Cost-effectiveness of pneumococcal conjugate vaccine: evidence from the first 5 years of use in the United States incorporating herd effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-207

Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-207

National impact of universal childhood immunization with pneumococcal conjugate vaccine on outpatient medical care visits in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-207

Health care utilization for pneumonia in young children after routine pneumococcal conjugate vaccine use in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-207

The current burden of pneumococcal disease in England and Wales

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-207

Pneumococcal pneumonia in the UK--how herd immunity affects the cost-effectiveness of 7-valent pneumococcal conjugate vaccine (PCV)

21 January 2018

1 reference

12 December 2020

The Dynamics of Bacteria in the Middle Ear During the Course of Acute Otitis Media With Tympanostomy Tube Otorrhea

1 reference

12 December 2020

Pneumococcal serogroups and serotypes in severe pneumococcal pneumonia in Belgian children: theoretical coverage of the 7-valent and 9-valent pneumococcal conjugate vaccines

1 reference

12 December 2020

Risk factors for invasive pneumococcal disease in children in the era of conjugate vaccine use

1 reference

12 December 2020

Serotypes and antimicrobial susceptibilities of invasive Streptococcus pneumoniae pre- and post-seven valent pneumococcal conjugate vaccine introduction in Alberta, Canada, 2000-2006

1 reference

12 December 2020

Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: Opportunities for prevention in the conjugate vaccine era

1 reference

12 December 2020

Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study

1 reference

12 December 2020

Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease--United States, 1998-2003

1 reference

12 December 2020

Cost effectiveness of adding 7-valent pneumococcal conjugate (PCV-7) vaccine to the Norwegian childhood vaccination program

1 reference

12 December 2020

Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine

1 reference

12 December 2020

Impact of conjugate 7-valent vaccination in Belgium: addressing methodological challenges

1 reference

12 December 2020

[Streptococcus pneumoniae serotypes involved in children with pleural empyemas in France]

1 reference

12 December 2020

Advances in pneumococcal vaccines: the 13-valent pneumococcal conjugate vaccine received market authorization in Europe

1 reference

12 December 2020

The impact of the heptavalent pneumococcal conjugate vaccine on the epidemiology of acute otitis media complicated by otorrhea

1 reference

12 December 2020

Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children: randomized, controlled trial of a 7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conju

1 reference

12 December 2020

Nasopharyngeal Pneumococcal Carriage after Combined Pneumococcal Conjugate and Polysaccharide Vaccination in Children with a History of Recurrent Acute Otitis Media

1 reference

12 December 2020

Cost effectiveness analysis of heptavalent pneumococcal conjugate vaccine in Germany considering herd immunity effects

1 reference

12 December 2020

Emergence of Invasive Pneumococcal Disease Caused by Nonvaccine Serotypes in the Era of 7-Valent Conjugate Vaccine

1 reference

12 December 2020

Cost-effectiveness analysis of the 10- and 13-valent pneumococcal conjugate vaccines in Argentina

1 reference

12 December 2020

Childhood empyema: limited potential impact of 7-valent pneumococcal conjugate vaccine

1 reference

12 December 2020

Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2334-12-207

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22954038%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

12 February 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22954038%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

PubMed publication ID

22954038

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22954038%20AND%20SRC:MED&resulttype=core&format=json